.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Excitotoxicity in Neurological Diseases
. Ed(S): Ferrarese, Carlo (University Of Milano-Bicocca, Ospedale San Gerardo, Monza, Italy); Beal, M. Flint (Cornell University, New York)
€ 201.46
FREE Delivery in Ireland
Description for Excitotoxicity in Neurological Diseases
Hardback. Divided into two parts, this book covers almost all basic mechanisms of excitotoxicity, from glutamate metabolism, release, activity on various pre- and post-synaptic receptors, reuptake and their regulations. It also focuses on each neurologic disorder where this mechanism seems to play a major role. Editor(s): Ferrarese, Carlo (University of Milano-Bicocca, Ospedale San Gerardo, Monza, Italy); Beal, M. Flint (Cornell University, New York). Num Pages: 362 pages, biography. BIC Classification: PSAN. Category: (G) General (US: Trade); (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 234 x 156 x 22. Weight in Grams: 708.
It can be reasonably anticipated that, over the next generations, the proportion of elderly people will remarkably increase and, with this, the number ofpersons suffering from acute (e.g. cerebral ischemia) or chronic neurodegenerative disorders. To date, approved drugs only alleviate the symptoms ofthese diseases (for instance, acetylcholinesterase inhibitors in Alzheimer disease and L-dopa and dopamine-agonists in Parkinson disease), while none seems to stop the progression of the degenerative processes underlying them. The development of effective preventive or protective therapies has been impeded by the limitations of our knowledge of the causes and the mechanisms by which neurons die in neurodegenerative ... Read more
It can be reasonably anticipated that, over the next generations, the proportion of elderly people will remarkably increase and, with this, the number ofpersons suffering from acute (e.g. cerebral ischemia) or chronic neurodegenerative disorders. To date, approved drugs only alleviate the symptoms ofthese diseases (for instance, acetylcholinesterase inhibitors in Alzheimer disease and L-dopa and dopamine-agonists in Parkinson disease), while none seems to stop the progression of the degenerative processes underlying them. The development of effective preventive or protective therapies has been impeded by the limitations of our knowledge of the causes and the mechanisms by which neurons die in neurodegenerative ... Read more
Product Details
Format
Hardback
Publication date
2003
Publisher
Kluwer Academic Publishers United States
Number of pages
362
Condition
New
Number of Pages
362
Place of Publication
New York, NY, United States
ISBN
9781402076800
SKU
V9781402076800
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Excitotoxicity in Neurological Diseases